Long-Term Care

Cipro and related antibiotics increase MRSA risk in LTC settings

MDS 3.0 Insider, April 25, 2014

Want to receive articles like this one in your inbox? Subscribe to MDS 3.0 Insider!

Long-term care residents on a fluoroquinolone antibiotic such as Cipro are at an increased risk for methicillin-resistant Staphylococcus aureus, as reported in Clinical Infectious Diseases.
Investigators at the Institut Pasteur in Paris tracked about 450 long-term care residents who were not colonized with Staphylococcus aureus at the time of admission. Of this group, 76 developed MRSA. In comparing the infected residents with a control group, the researchers identified fluoroquinolone use as a factor associated with the MRSA acquisition. More than 93% of the strains were resistant to fluoroquinolones, they found.

To continue reading, visit our blog MDSCentral.

 

 

 



Want to receive articles like this one in your inbox? Subscribe to MDS 3.0 Insider!

Most Popular